Page not found
Search results
-
Floxed Prostaglandin D2 Receptor Alleles
This research targets DP1. ...
cttc_admin - 09/16/2015 - 2:42pm
-
Seven Vanderbilt technologies earn patent protection in January
... Allosteric Modulators of the Muscarinic Acetylcholine Receptor M4 Logan Baker Jeff Conn Darren Engers ...
sommers - 02/01/2024 - 12:21pm
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
... research collaboration agreement for two novel series of M4 receptor modulator compounds, including NMRA-266, in February 2022. ... with Neumora was centered around the M4 muscarinic receptor, which NMRA-266 targets through positive allosteric modulation. In ...
sommers - 01/17/2024 - 10:08am
-
Eight Vanderbilt technologies earn patent protection in December
... Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1 Aaron Bender Jeff Conn Julie Engers ...
sommers - 01/17/2024 - 10:45am
-
Five Vanderbilt technologies earn patent protection in November
... 11,820,757 Antagonists of the Muscarinic Acetylcholine Receptor M4 Logan Baker Aaron Bender Jeff Conn ...
sommers - 11/30/2023 - 11:40am
-
GluN2B Floxed Mice (also called NR2B, glutamate receptor 2B)
Allows for targeted deletion of the GluN2B subunit of NMDA receptors in specific cells or at specific times during development, juvenile, or adult stages. C57BL6/J background. ...
cttc_admin - 05/31/2023 - 2:06pm
-
ThermoFisher Scientific - Research Interest Areas
... analysis; fluorescent probes for measuring cell health & content; functional flow cytometry reagents; fluorescent assays run on Qubit ...
cttc_admin - 01/30/2024 - 12:26pm
-
Five Vanderbilt technologies earn patent protection in July
... Allosteric Modulators of the Muscarinic Acetylcholine Receptor M4 Jeff Conn Julie Engers Darren Engers ...
sommers - 11/07/2022 - 8:20am
-
mGlu3 NAMs as Therapeutics for Chemoresistant Tumors
... About the Target Targeting metabotropic glutamate receptor 3 (mGlu3) has been linked as a potential therapeutic to many ... studied to determine that mGlu3 negatively modulates BMP receptor signaling and increases the tumorigenic potential of glioma-initiating ...
cttc_admin - 01/23/2024 - 4:42pm
-
Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders
... About the Target Targeting metabotropic glutamate receptor 3 (mGlu3) has been linked as a potential therapeutic to many ...
cttc_admin - 01/23/2024 - 4:43pm